Home › Funds › Royce & Associates › XRAY
Royce & Associates position in XRAY
DENTSPLY SIRONA INC · Health Care
Latest position (Q2 2026)847.49K sh
Reported value held$8.99M
Portfolio Weight0.07%
First reportedQ4 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 11.60K | $220.07K | New |
| Q1 2025 | 11.60K | $173.23K | Hold |
| Q2 2025 | 10.70K | $169.96K | Reduce |
| Q3 2025 | 11.60K | $147.14K | Add |
| Q1 2026 | 455.68K | $5.29M | New |
| Q2 2026 | 847.49K | $8.99M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding XRAY
- BlackRock Inc 26.71M sh · $283.40M · Q2 2026
- Vanguard Group 21.86M sh · $249.87M · Q4 2025
- AQR Capital Management 10.46M sh · $110.18M · Q2 2026
- Lazard Asset Management 8.27M sh · $87.74M · Q2 2026
- Geode Capital Management 5.65M sh · $59.96M · Q2 2026
- Marshall Wace 3.80M sh · $40.32M · Q2 2026
- D. E. Shaw & Co 2.99M sh · $31.69M · Q2 2026
- Bank of America Corp 2.92M sh · $31.00M · Q2 2026
- Northern Trust Corp 2.59M sh · $27.49M · Q2 2026
- Charles Schwab Investment Management 2.52M sh · $26.69M · Q2 2026
- Morgan Stanley 2.00M sh · $21.27M · Q2 2026
- UBS Group AG 1.97M sh · $20.87M · Q2 2026